Overall, these results highlight how α-syn can affect the aggressiveness of melanoma and its evolution, not only by enhancing cellular motility through the transport and trafficking of CD81, L1CAM, and N-cadherin but also by shaping the immune landscape of the tumor microenvironment. Here, CDH2 is linked to melanoma.